BRIEF published on 03/16/2026 at 07:29, 7 days 4 hours ago UBS AG annonce l'ordre du jour de son assemblée générale annuelle de 2026 Proposition De Dividende Élections Du Conseil D'administration Réduction Du Capital Social Assemblée Générale Annuelle D'UBS 2026 Détails De L'ordre Du Jour
BRIEF published on 03/16/2026 at 07:10, 7 days 4 hours ago Hypoport Reports Strong Growth in 2025 EBIT Growth Future Outlook Hypoport 2025 Financial Results Mortgage Recovery
BRIEF published on 03/16/2026 at 07:10, 7 days 4 hours ago Hypoport prévoit une forte croissance en 2025 Croissance De L'EBIT Perspectives D'avenir Hypoport Résultats Financiers De 2025 Recouvrement Hypothécaire
BRIEF published on 03/16/2026 at 07:07, 7 days 4 hours ago Julius Baer Group Announces Board Changes Board Of Directors Julius Baer Group Gender Diversity Olga Zoutendijk Colin Bell
BRIEF published on 03/16/2026 at 07:07, 7 days 4 hours ago Le groupe Julius Baer annonce des changements au sein de son conseil d'administration Conseil D'administration Groupe Julius Baer Olga Zoutendijk Colin Bell Diversité Des Genres
BRIEF published on 03/16/2026 at 07:05, 7 days 4 hours ago BioVersys Gets FDA Nod for BV100 Phase 3 Trial for Pneumonia FDA Approval Phase 3 Trial BV100 BioVersys CRAB Infections
BRIEF published on 03/16/2026 at 07:05, 7 days 4 hours ago BioVersys obtient l'approbation de la FDA pour son essai de phase 3 du BV100 contre la pneumonie Approbation De La FDA Essai De Phase 3 BV100 BioVersys Infections À CRAB
BRIEF published on 03/16/2026 at 07:04, 7 days 4 hours ago Julius Baer Releases 2025 Annual and Sustainability Reports Wealth Management Financial Statement Sustainability Report Julius Baer Annual Report 2025
BRIEF published on 03/16/2026 at 07:04, 7 days 4 hours ago Julius Baer publie ses rapports annuels et de développement durable pour 2025 États Financiers Julius Baer Gestion De Patrimoine Rapport Sur Le Développement Durable Rapport Annuel 2025
BRIEF published on 03/16/2026 at 06:05, 7 days 5 hours ago Corporate Clients Shift Towards Non-Bank Financial Institutions AI Technology CIB Challenges Non-Bank Competition Client Expectations Innovation Obstacles
Published on 03/23/2026 at 08:00, 3 hours 33 minutes ago ABRIDGED, PRELIMINARY AND UNAUDITED QUARTERLY AND FULL YEAR RESULTS AND DETAILS OF MANAGEMENT CONFERENCE Call for the Fourth Quarter and Full Year Ended December 31, 2025 ("The Quarter" or "Q4 2025" and "FY 2025" Respectively)
Published on 03/23/2026 at 02:00, 9 hours 33 minutes ago FutureGen Industries Announces Open Market Investments
Published on 03/23/2026 at 11:06, 26 minutes ago Aroundtown SA: Release of a capital market information
Published on 03/23/2026 at 11:05, 28 minutes ago ASUS Unveils Complete Portfolio Support for Intel® Core™ 200S Series
Published on 03/23/2026 at 11:05, 28 minutes ago BRAIN Biotech has been granted a key patent for its CRISPR-BMC genome-editing technology
Published on 03/23/2026 at 10:30, 1 hour 3 minutes ago TK Elevator appoints Brad Selleck as Chief Operating Officer; Vincent Della Valle to retire
Published on 03/23/2026 at 10:30, 1 hour 3 minutes ago TK Elevator creates the role of Chief Legal Officer, appoints Lars Sjobring
Published on 03/23/2026 at 08:10, 3 hours 23 minutes ago Entrée en négociations exclusives de cession de la participation dans Winncare
Published on 03/20/2026 at 19:00, 2 days 16 hours ago AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days 16 hours ago AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 17 hours ago Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 17 hours ago Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA
